Paediatric Sedation With Intranasal Dexmedetomidine for Magnetic Resonance Imaging
Acta Anaesthesiologica Scandinavica · 2027-01 · 71 (1)
DOI: 10.1111/aas.70398 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Anaesthesiologica Scandinavica, online erschienen am 20.11.2026. Verfasst von Katrine Dueholm Nissen und 6 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Paediatric sedation for magnetic resonance imaging presents significant challenges. To facilitate this, our department decided to implement paediatric sedation with intranasal dexmedetomidine for children requiring a scan. We aim to summarise lessons learnt from implementation of intranasal dexmedetomidine, comparing time consumption and effectiveness.
Methods
We conducted a prospective observational study. Data from children sedated with intranasal dexmedetomidine 4 μg/kg ( n = 51) were collected prospectively and compared with historical controls ( n = 100) collected from children previously anaesthetized with either sevoflurane or propofol.
Results
Sedation with intranasal dexmedetomidine resulted in a longer hospital stay (214 min vs. 133 min [67.94–94.74]), longer time to sufficient sedation (60 min vs. 26 min [29.31, 38.68]) and longer time in the post‐operative unit (112 min vs. 64, 48 min [36.11, 60, 80]). Of children sedated with dexmedetomidine, 75% were cooperative with the intranasal administration of the medicine and 37% were successfully sedated with dexmedetomidine as the sole sedative. In the historical controls, 43% of patients required airway management compared to 1.9% in the dexmedetomidine group [0.00, 0.19]. In the control group, 20% had post‐sedation agitation compared to none in the dexmedetomidine group. No serious bradycardia or desaturation was registered in either group.
Conclusion
Paediatric sedation with intranasal dexmedetomidine as the sole medicament for magnetic resonance imaging is more time‐consuming compared to sevoflurane and propofol. Sedation with intranasal dexmedetomidine has a relatively low success rate but is without serious adverse events. Editorial Comment This single center case‐control study with prospective datacollection for the case group, intranasal dexmedetomidine and comparison with a historical non‐dexmedetomidine sedation group described multiple possible clinical advantages with intranasal dexmedetomidine administration as it was done here.
Zitieren
APA
Nissen, K. D., Wolf, A., Keller, J., Moos, C., Petersen, S. R., Bhavsar, R., & Strøm, T. (2027). Paediatric Sedation With Intranasal Dexmedetomidine for Magnetic Resonance Imaging. Acta Anaesthesiologica Scandinavica, 71(1). https://doi.org/10.1111/aas.70398
Vancouver
Nissen KD, Wolf A, Keller J, Moos C, Petersen SR, Bhavsar R, et al. Paediatric Sedation With Intranasal Dexmedetomidine for Magnetic Resonance Imaging. Acta Anaesthesiologica Scandinavica. 2027;71(1). doi:10.1111/aas.70398
BibTeX
@article{Nissen2027,
author = {Nissen, Katrine Dueholm and Wolf, Andras and Keller, Jeppe and Moos, Caroline and Petersen, Sofie Ronja and Bhavsar, Rajesh and Strøm, Thomas},
title = {Paediatric Sedation With Intranasal Dexmedetomidine for Magnetic Resonance Imaging},
journal = {Acta Anaesthesiologica Scandinavica},
year = {2027},
volume = {71},
number = {1},
doi = {10.1111/aas.70398}
}
EUVIMED